Prognostic value positron emission tomography with [18F]fluoro-2-deoxy-D-glucose in the low-grade glioma.

作者: Olivier De Witte , Marc Levivier , Philippe Violon , Isabelle Salmon , Philippe Damhaut

DOI: 10.1097/00006123-199609000-00007

关键词: Positron emission tomography2-Deoxy-D-glucoseCentral nervous system diseaseNeurosurgeryNuclear medicineGliomaBiopsySurvival rateMedicineMalignant transformation

摘要: OBJECTIVE : The natural history of the supratentorial low-grade glioma (LGG) adult is variable, and its malignant transformation hardly predictable. Because positron emission tomography with [ 18 F]fluoro-2-deoxy-D-glucose (FDG) has prognostic value in high-grade gliomas, this study was designed to search for a possible relationship between glucose metabolism risk evolution LGGs. METHODS Positron FDG performed 28 patients LGGs (22 at time diagnosis 6 after diagnosis). A metabolic grading system based on visual inspection tomographic images used. RESULTS In 19 patients, no area uptake higher than white matter detected (metabolic Grade 1). All those were alive end follow-up period. Only one presented histological modification 7 months diagnosis. Nine areas increased 2 or 3). Those found tumor eight an radionecrosis one. Of nine hot spots, six died, two had recurrence but period, patient signs recurrence. CONCLUSIONS presence histologically proven LGG predicts, most cases, deleterious evolution. This feature, detectable noninvasive procedure, may provide clue cellular changes, announcing that retains features LGG. Protocols aggressive therapeutic strategies situation should be considered evaluation. (Neurosurgery

参考文章(42)
K Herholz, K Wienhard, W D Heiss, Validity of PET studies in brain tumors. Cerebrovascular and brain metabolism reviews. ,vol. 2, pp. 240- 265 ,(1990)
J. Hildebrand, Julien Mendlewicz, André Luxen, Serge Goldman, Sophie Dethy, Françoise Lotstra, Françoise Biver, Etienne Stanus, David Wikler, Basal ganglia and frontal lobe glucose metabolism. A reproducibility positron emission tomography study. Journal of Neuroimaging. ,vol. 5, pp. 219- 226 ,(1995) , 10.1111/JON199554219
R Folkerth, J S Loeffler, P A Carvalho, E Alexander, R B Schwartz, B L Holman, Radiation necrosis vs high-grade recurrent glioma: differentiation by using dual-isotope SPECT with 201TI and 99mTc-HMPAO. American Journal of Neuroradiology. ,vol. 12, pp. 1187- 1192 ,(1991)
Serge Blecic, Sophie Dethy, André Luxen, Jerzy Hildebrand, Serge Goldman, Marc Levivier, Carbon-11-Methionine and Fluorine-18-FDG PET Study in Brain Hematoma The Journal of Nuclear Medicine. ,vol. 35, pp. 1162- 1166 ,(1994)
Gundula Thiel, Tanka Losanowa, Dieter Kintzel, Gunter Nisch, Hubert Martin, Klaus Vorpahl, Regine Witkowski, Karyotypes in 90 human gliomas Cancer Genetics and Cytogenetics. ,vol. 58, pp. 109- 120 ,(1992) , 10.1016/0165-4608(92)90095-P
OTTO WARBURN, FRANK DICKENS, THE METABOLISM OF TUMORS The American Journal of the Medical Sciences. ,vol. 182, pp. 123- ,(1931) , 10.1097/00000441-193107000-00022
Jane B. Alavi, Abass Alavi, John Chawluk, Michael Kushner, John Powe, William Hickey, Martin Reivich, Positron emission tomography in patients with glioma a predictor of prognosis Cancer. ,vol. 62, pp. 1074- 1078 ,(1988) , 10.1002/1097-0142(19880915)62:6<1074::AID-CNCR2820620609>3.0.CO;2-H
Olivier De Witte, Jerzy Hildebrand, Andre Luxen, Serge Goldman, Acute Effect of Carmustine on Glucose Metabolism in Brain and Glioblastoma Cancer. ,vol. 74, pp. 2836- 2842 ,(1994) , 10.1002/1097-0142(19941115)74:10<2836::AID-CNCR2820741015>3.0.CO;2-M
Juan Galarraga, David J. Loreck, Jon F. Graham, Robert L. DeLaPaz, B. H. Smith, Douglas Hallgren, C. J. Cummins, Glucose metabolism in human gliomas: correspondence of in situ and in vitro metabolic rates and altered energy metabolism. Metabolic Brain Disease. ,vol. 1, pp. 279- 291 ,(1986) , 10.1007/BF00999357
S. Leenstra, D. Troost, T.J.M. Hulsebos, D. Andries Bosch, Genetic versus histological grading in stereotactic biopsies. Stereotactic and Functional Neurosurgery. ,vol. 63, pp. 56- 62 ,(1994) , 10.1159/000100292